PH27352A - 4-Benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants - Google Patents

4-Benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants

Info

Publication number
PH27352A
PH27352A PH41759A PH41759A PH27352A PH 27352 A PH27352 A PH 27352A PH 41759 A PH41759 A PH 41759A PH 41759 A PH41759 A PH 41759A PH 27352 A PH27352 A PH 27352A
Authority
PH
Philippines
Prior art keywords
anticonvulsants
triazol
dihydro
benzyl
ones
Prior art date
Application number
PH41759A
Other languages
English (en)
Inventor
John M Kane
Francis P Miller
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of PH27352A publication Critical patent/PH27352A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH41759A 1989-12-20 1990-12-20 4-Benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants PH27352A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/453,440 US4966909A (en) 1989-12-20 1989-12-20 4-benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-ones and their use as anticonvulsants

Publications (1)

Publication Number Publication Date
PH27352A true PH27352A (en) 1993-06-21

Family

ID=23800598

Family Applications (1)

Application Number Title Priority Date Filing Date
PH41759A PH27352A (en) 1989-12-20 1990-12-20 4-Benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants

Country Status (12)

Country Link
US (1) US4966909A (da)
EP (1) EP0435177B1 (da)
JP (1) JP2968053B2 (da)
KR (1) KR0154529B1 (da)
AT (1) ATE113591T1 (da)
AU (1) AU634003B2 (da)
DE (1) DE69013871T2 (da)
DK (1) DK0435177T3 (da)
ES (1) ES2066096T3 (da)
IE (1) IE64989B1 (da)
PH (1) PH27352A (da)
ZA (1) ZA9010080B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966909A (en) * 1989-12-20 1990-10-30 Merrell Dow Pharmaceuticals 4-benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-ones and their use as anticonvulsants
SE470120B (sv) * 1992-04-03 1993-11-08 Whirlpool Int Förfarande för styrning av mikrovågsenergin i en mikrovågsugn och mikrovågsugn för genomförande av förfarandet
EP0821676B1 (en) * 1995-04-20 2000-07-05 Aventis Pharmaceuticals Inc. 3-phenyl-1,4-dialkyl-1,2,4-triazolium salts and their use as antidepressants
TW467902B (en) 1996-07-31 2001-12-11 Bristol Myers Squibb Co Diphenyl heterocycles as potassium channel modulators
AU4933199A (en) * 1998-08-03 2000-02-28 Sumitomo Chemical Company, Limited Triazolone derivatives, use thereof, and intermediate therefor
US6156775A (en) * 1999-03-01 2000-12-05 Novartis Ag Use of fluorinated triazoles in treating affective and attention disorders
TW200505441A (en) 2003-03-24 2005-02-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitorsⅠ
US7400548B2 (en) * 2005-02-09 2008-07-15 International Business Machines Corporation Method for providing multiple reads/writes using a 2read/2write register file array
EP2142520A1 (en) 2007-03-29 2010-01-13 F. Hoffmann-Roche AG Non-nucleoside reverse transcriptase inhibitors
JP2022189000A (ja) 2021-06-10 2022-12-22 Ｔｍｔマシナリー株式会社 紡糸引取装置

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1126882B (de) * 1960-05-03 1962-04-05 Boehringer Sohn Ingelheim Verfahren zur Herstellung von 1,2,4-Triazolonen-(5)
BE621842A (da) * 1962-08-27
GB1068083A (en) * 1964-04-02 1967-05-10 Philippe Gold Aubert í¸-1,2,4-triazolone-(5) derivatives
US3621099A (en) * 1969-03-05 1971-11-16 Charles R Jacobson Therapeutic compositions and methods for stimulating the central nervous system
DE3173083D1 (en) * 1980-03-22 1986-01-16 Fbc Ltd Pesticidal heterocyclic compounds, processes for preparing them, compositions containing them, and their use
DD153953A3 (de) * 1980-04-01 1982-02-17 Gottfried Schuster Mittel zur chemotherapie von virosen der kulturpflanzen
DD160447A1 (de) * 1981-03-26 1983-08-03 Johannes Dost Herbizide mittel, die 1,2,4-triazolinone-(5) enthalten
BE894856A (fr) * 1982-10-28 1983-02-14 Fahlberg List Veb Compositions herbicides a base d'un derive de la 1,2,4-triazolinone-(5)
JP2593084B2 (ja) * 1986-12-19 1997-03-19 メレルダウファーマスーティカルズ インコーポレーテッド ５−アリールー３ｈ−１，２，４−トリアゾールー３−オン類の神経変性障害の処置への用途
PH24094A (en) * 1986-12-19 1990-03-05 Merrell Dow Pharma 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
US4966909A (en) * 1989-12-20 1990-10-30 Merrell Dow Pharmaceuticals 4-benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-ones and their use as anticonvulsants

Also Published As

Publication number Publication date
KR910011807A (ko) 1991-08-07
EP0435177B1 (en) 1994-11-02
ATE113591T1 (de) 1994-11-15
IE64989B1 (en) 1995-09-20
ES2066096T3 (es) 1995-03-01
JP2968053B2 (ja) 1999-10-25
IE904599A1 (en) 1991-07-03
DK0435177T3 (da) 1994-11-21
AU634003B2 (en) 1993-02-11
KR0154529B1 (ko) 1998-11-16
AU6808190A (en) 1991-06-27
ZA9010080B (en) 1991-10-30
EP0435177A2 (en) 1991-07-03
JPH04128271A (ja) 1992-04-28
DE69013871D1 (de) 1994-12-08
EP0435177A3 (en) 1992-01-08
US4966909A (en) 1990-10-30
DE69013871T2 (de) 1995-03-09

Similar Documents

Publication Publication Date Title
IN172468B (da)
IL93576A0 (en) Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis,inflammation and as immunosuppressants
EP0236684A3 (en) Galanthamine or analogues thereof for treating alzheimer's disease
GR3004281T3 (da)
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
MY115977A (en) Synthetic excitatory amino acids
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
GR3035682T3 (en) Non-glycosylated fgf-4 and compositions containing the same.
EP0435177A3 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
MY107449A (en) Bcrf1 proteins as inhibitors of interferon- gamma.
PH24094A (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
AU553269B2 (en) 2,3-diaryl-5-halo thiophenes
EP0340391A3 (en) 1,4-disubstituted-2,3,4,6-tetrahydroxy-1,4-diphosphorinane and their oxides or sulfides
MY105555A (en) Heterocyclicguanidines as 5ht 3 antagonists.
EP0116628A4 (en) 1-ACYL-3-PYRIDYLMETHYLGUANIDINE AND THEIR USE AS AN ANI-HYPERTENSIVE.
ZA929176B (en) Aminoalkyl-substituted 5,6-dihydro-dibenz(b e)azepine-6,11-dione-11-oximes.
ZA91236B (en) 4,4'-(9h-fluoren-9-ylidinebis(methylene))-bispyrimidine for treating neurological disorders
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
EP0412941A3 (en) Phospholipids for the treatment of multiple sclerosis
ITMI910967V0 (it) Regolo per la determinazione dell'intensita' del dolore
MX9405923A (es) Mejoras en proceso para humectar y suavizar la piel.